METHODS AND COMPOSITIONS DESCRIBED AS SYNTHETIC BETA-1,6-GLUCOSAMINOLIGOSACCHARIDES Russian patent published in 2014 - IPC C07D207/456 C07C327/20 C07C327/32 C07H3/06 C08B37/00 C07K14/31 

Abstract RU 2532911 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to oligosaccharide carrier conjugates effective for treating and preventing infectious diseases and containing an oligosaccharide conjugated with the carrier through a linker of formulas

VIIIa

or

VIIIb:

wherein n is more than 1, m is specified in 1-10, p is specified in 1-20 and R represents H or alkyl; the linker is bound to an oligosaccharide oxygen atom through a terminal CH2 group, and the linker is bound through a terminal CO group with an amino group of the carrier compound by an amide bond; the oligosaccharide is β-1-6 related glucosamine, and the carrier is peptide, protein, polysaccharide, nucleic acid, lipid or tetanus toxoid.

EFFECT: there are presented new conjugates effective to stimulate the immune response, and a method for preparing them.

21 cl, 12 ex, 23 dwg, 1 tbl

Similar patents RU2532911C2

Title Year Author Number
POLYSACCHARIDE-PROTEIN CONJUGATE POLYSACCHARIDE-PROTEIN FOR INDUCING IMMUNE RESPONSE AND PROTECTION AGAINST Staphylococcus aureus INFECTION, METHODS OF CONJUGATE OBTAINING (VERSIONS), CONJUGATE-CONTAINING COMPOSITION AND METHODS OF INDUCING IMMUNE RESPONSE AND PREVENTION OF Staphylococcus aureus INFECTION 2010
  • Freese Stephen John
  • Anderson Annaliesa
  • Pavliak Viliam
  • Jansen Kathrin Ute
  • Dodge Ingrid Lea
  • Scott Tracey Dee
  • Nanra Jasdeep Singh
  • Murphy Ellen
  • Creen Bruce Arthur
RU2531234C2
CONJUGATION OF STAPHYLOCOCCUS AUREUS TYPE 5 AND TYPE 8 CAPSULAR POLYSACCHARIDES 2010
  • Berti Franchesko
  • Konstantino Paolo
  • Romano Marija Rozarija
RU2603267C2
IMMUNOGENIC COMPOSITION APPLICABLE FOR STAPHYLOCOCCUS VACCINATION 2009
  • Kastado Sindi
  • Lekren'E Nikola P'Er Fernan
  • Nejt Sesil' Anna
  • Pulman Jan
RU2521501C2
IMMUNOGENIC CONJUGATE OF BETA-PROPIONAMIDE-BOUND POLYSACCHARIDE WITH PROTEIN APPLIED AS VACCINE 1999
  • Mishon Fransis
  • Khuang Chun-Khsien
  • Uitz Katrin
RU2249463C2
MOLECULE CONTAINING spr0096 AND spr2021 2012
  • Kostantino Paolo
  • Romano Mariya Rozariya
RU2636350C2
IMMUNOGENIC COMPOSITION 2005
  • Kastado Sindi
  • Lekren'E Nikola P'Er Fernan
  • Nejt Sesil' Anna
  • Pulman Jan
RU2402347C2
IMMUNOGENIC COMPOSITIONS OF STAPHYLOCOCCUS AUREUS ANTIGENS 2010
  • Anderson Annaliesa
  • Pavliak Viliam
  • Jansen Kathrin Ute
  • Dodge Ingrid Lea
  • Baker Steven Morris
  • Nanra Jasdeep Singh
  • Murphy Ellen
  • Green Bruce Arthur
  • Ruppen Mark Edward
  • Timofeyeva Yekaterina
RU2536981C9
PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 5 AND TYPE 8 CAPSULAR SACCHARIDES 2010
  • Kostantino Paolo
  • Romano Marija Rozarija
  • Berti Franchesko
RU2579900C2
BACTERIAL VACCINE AND METHODS FOR PRODUCTION THEREOF 2014
  • Ella Krishna Murtkhi
  • Ramasami Venkatesan
  • Naidu Mandalapu Gangadkhara
RU2684615C2
VACCINATION WITH MENINGOCOCCAL COJUGATES 2006
  • Marshall Kehmeron Dzhon
RU2429011C2

RU 2 532 911 C2

Authors

P'Er Dzheral'D B.

Nifant'Ev Nikolaj Ehduardovich

Tsvetkov Jurij Evgen'Evich

Gening Marina Leonidovna

Dates

2014-11-20Published

2009-07-21Filed